GreenLight Biosciences Holdings (GRNA) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Medford, MA, 미국. 현재 CEO는 Andrey Juan Zarur.
GRNA 을(를) 보유 IPO 날짜 2022-02-03, 280 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $45.43M.
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
